ArticleTransboundary and emerging diseases2021
Colistin-resistant Enterobacter kobei carrying mcr-9.1 and bla
Article in Transboundary and emerging diseases, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed, 20 citations in OpenAlex.
- First Report of blaMicrobiologyOpen · 2026Article
- Multidrug-Resistant Bacteria in South Atlantic Cetaceans over a Decade of Surveillance.Microorganisms · 2026Article
- Genomic epidemiology of carbapenemase-producingMicrobiology spectrum · 2026Article
- Article
- Gram-negative bacilli carrying mcr gene in Brazil: a pathogen on the rise.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2023Review
- Exploring the epidemiology of mcr genes, genetic context and plasmids in Enterobacteriaceae originating from pigs and humans on farms in Thailand.The Journal of antimicrobial chemotherapy · 2023Article
- Modified Drug-Susceptibility Testing and Screening Culture Agar for Colistin-SusceptibleJournal of clinical microbiology · 2022Article
- Epidemiology and Traits of Mobile Colistin Resistance (Microorganisms · 2022Review
- Imported One-Day-Old Chicks as Trojan Horses for Multidrug-Resistant Priority Pathogens HarboringApplied and environmental microbiology · 2022Article
- Enterobacteriaceae in soils and atmospheric dust aerosol accumulations of Moscow city.Current research in microbial sciences · 2022Article
- Genomic Analysis of a Highly Virulent NDM-1-ProducingFrontiers in microbiology · 2022Article
- Highly divergent herpesviruses in threatened river dolphins from Brazil.Scientific reports · 2021Article
- Colistin-resistant Enterobacter kobei carrying mcr-9.1 and blaTransboundary and emerging diseases · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors at 2 institutions in 1 country.
Funding
Abstract
The emergence of mobile mcr genes mediating resistance to colistin is a critical public health issue that has hindered the treatment of serious infections caused by multidrug-resistant pathogens in humans and other animals. We report the emergence of the mcr-9.1 gene in a polymyxin-resistant extended-spectrum β-lactamase (ESBL)-producing Enterobacter kobei infecting a free-living franciscana dolphin (Pontoporia blainvillei), threatened with extinction in South America. Genomic analysis confirmed the presence of genes conferring resistance to clinically relevant β-lactam [bla
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.